TABLE 1.

Patients characteristics

	Patients, N = 121	Controls, N = 14
Median age (range)	57 (2–85)	52.5 (22–69)
Sex, female/male	61/60	7/7
Disease severity (VSAA/SAA/NSAA) at diagnosis, n (%)	32 (26%)/45 (37%)/44 (37%)
Peripheral blood counts
Neutrophils, ×10*9/L median (range)	0.5 (0.0–4.0)
Lymphocytes, ×10*9/L median (range)	1.5 (0.18–5.8)
Reticulocytes, ×10*9/L median (range)	21 (1–104)*
Treatment
Rabbit ATG/horse ATG, n (%)**	97 (80%)/21 (18%)
HSCT, n ***	28
VSAA/SAA/NSAA, n (%)	11 (39%)/11 (39%)/6 (22%)

Note: *93 patients, ** For three patients, data on ATG formulation was missing, *** second or third‐line treatment.

Abbreviation: HSCT‐hematopoietic stem cell transplantation.